Pharmaceutical Care in Depression: A Survey of Stigma, Confidence, Attitudes, and Barriers

References

• Feigin V. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545–1602. doi:10.1016/S0140-6736(16)31678-627733282
   PubMed Web of Science ®Google Scholar
• Ghanem M, Gadallah M, Meky FA, Mourad S, El-Kholy G. National survey of prevalence of mental disorders in Egypt: preliminary survey. East Mediterr Health J. 2009;15(1):65–75.19469428
   PubMedGoogle Scholar
• El-Gilany A-H, Elkhawaga GO, Sarraf BB. Depression and its associated factors among elderly: a community-based study in Egypt. Arch Gerontol Geriatr. 2018;77:103–107. doi:10.1016/j.archger.2018.04.01129734054
   PubMed Web of Science ®Google Scholar
• Kelly LS, Mckenna HP. Victimization of people with enduring mental illness in the community. J Psychiatr Ment Health Nurs. 1997;4(3):185–191. doi:10.1046/j.1365-2850.1997.00054.x9325799
   PubMedGoogle Scholar
• Okasha A. Expressed emotion, perceived criticism, and relapse in depression: a replication in an Egyptian community. Am J Psychiatry. 1994;151(7):1001–1005. doi:10.1176/ajp.151.7.10018010354
   PubMed Web of Science ®Google Scholar
• Aamer Sarfraz M, Castle DA. Muslim suicide. Australas Psychiatry. 2002;10(1):48–50. doi:10.1046/j.1440-1665.2002.00392.x
   Google Scholar
• Endrawes G, O’Brien L, Wilkes L. Mental illness and Egyptian families. Int J Ment Health Nurs. 2007;16(3):178–187. doi:10.1111/j.1447-0349.2007.00465.x17535163
   PubMed Web of Science ®Google Scholar
• Bell S, McLachlan AJ, Aslani P, Whitehead P, Chen TF. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust New Zealand Health Policy. 2005;2(1):29. doi:10.1186/1743-8462-2-2916336646
   PubMedGoogle Scholar
• Gizzi LA, Slain D, Hare JT, Sager R. Assessment of a safety enhancement to the hospital medication reconciliation process for elderly patients. Am J Geriatr Pharmacother. 2010;8(2):127–135. doi:10.1016/j.amjopharm.2010.03.00420439062
   PubMed Web of Science ®Google Scholar
• Ranelli PL, Biss J. Physicians’ perceptions of communication with and responsibilities of pharmacists. J Am Pharm Assoc. 2000;40(5):625–630. doi:10.1016/s1086-5802(16)31102-0
   Google Scholar
• Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–543.2316538
   PubMedGoogle Scholar
• Keely JL. Pharmacist scope of practice. Ann Intern Med. 2002;136(1):79–85. doi:10.7326/0003-4819-136-1-200201010-0001411777367
   PubMed Web of Science ®Google Scholar
• Elmaaty MA, Elberry AA, Hussein RR, Khalil DM, Khalifa AE. Applicability of American college of clinical pharmacy (ACCP) competencies to clinical pharmacy practice in Egypt. Pharm Pract (Granada). 2020;18(3):1951. doi:10.18549/PharmPract.2020.3.195133005259
   PubMed Web of Science ®Google Scholar
• Saseen JJ, Ripley TL, Bondi D, et al. ACCP clinical pharmacist competencies. Pharmacotherapy. 2017;37(5):630–636. doi:10.1002/phar.192328464300
   PubMed Web of Science ®Google Scholar
• Crisp AH, Gelder MG, Rix S, Meltzer HI, Rowlands OJ. Stigmatisation of people with mental illnesses. Br J Psychiatry. 2000;177(1):4–7. doi:10.1192/bjp.177.1.410945080
   PubMed Web of Science ®Google Scholar
• Bell JS, Johns R, Chen TF. Pharmacy students’ and graduates’ attitudes towards people with schizophrenia and severe depression. Am J Pharm Educ. 2006;70(4):77. doi:10.5688/aj70047717136196
   PubMed Web of Science ®Google Scholar
• Eksteen H-C, Becker PJ, Lippi G. Stigmatization towards the mentally ill: perceptions of psychiatrists, pre-clinical and post-clinical rotation medical students. Int J Soc Psychiatry. 2017;63(8):782–791. doi:10.1177/002076401773586529067838
   PubMed Web of Science ®Google Scholar
• Knaak S, Mantler E, Szeto A. Mental illness-related stigma in healthcare: barriers to access and care and evidence-based solutions. Healthc Manage Forum. 2017;30(2):111–116. doi:10.1177/084047041667941328929889
   PubMedGoogle Scholar
• Shoji M, Fujiwara A, Onda M. Creation and validation of a semi-quantitative instrument to assess the confidence of pharmacists in medication consultation for patients with depression: the pharmacists’ confidence scale about medication consultation for depressive patients (PCMCD). Pharm Pract (Granada). 2019;17(4):1628. doi:10.18549/PharmPract.2019.4.162831897261
   PubMed Web of Science ®Google Scholar
• Kamusheva M, Ignatova D, Golda A, Skowron A. The potential role of the pharmacist in supporting patients with depression – a literature-based point of view. Integr Pharm Res Pract. 2020;9:49–63. doi:10.2147/IPRP.S23967232161716
   PubMed Web of Science ®Google Scholar
• Marques LAM, Galduroz JCF, Noto AR. Pharmaceutical care to patients treated with antidepressants. Rev Calid Asist Organo La Soc Esp Calid Asist. 2012;27(1):55–64. doi:10.1016/j.cali.2011.07.002
   Google Scholar
• McCullough MB, Petrakis BA, Gillespie C, et al. Knowing the patient: a qualitative study on care-taking and the clinical pharmacist-patient relationship. Res Social Adm Pharm. 2016;12(1):78–90. doi:10.1016/j.sapharm.2015.04.00526004019
   PubMed Web of Science ®Google Scholar
• Rossom RC, Shortreed S, Coleman KJ, et al. Antidepressant adherence across diverse populations and healthcare settings. Depress Anxiety. 2016;33(8):765–774. doi:10.1002/da.2253227320786
   PubMed Web of Science ®Google Scholar
• Kim S, Shin DW, Yun JM, et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016;67(3):506–512. doi:10.1161/HYPERTENSIONAHA.115.0673126865198
   PubMed Web of Science ®Google Scholar
• Samples H, Mojtabai R. Antidepressant self-discontinuation: results from the collaborative psychiatric epidemiology surveys. Psychiatr Serv. 2015;66(5):455–462. doi:10.1176/appi.ps.20140002125930223
   PubMed Web of Science ®Google Scholar
• Chong WW, Aslani P, Chen TF. Adherence to antidepressant medications: an evaluation of community pharmacists’ counseling practices. Patient Prefer Adherence. 2013;7:813–825. doi:10.2147/PPA.S4848623986631
   PubMed Web of Science ®Google Scholar
• Scheerder G, De Coster I, Van Audenhove C. Pharmacists’ role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008;59(10):1155–1160. doi:10.1176/ps.2008.59.10.115518832501
   PubMed Web of Science ®Google Scholar
• Rickles NM, Dube GL, McCarter A, Olshan JS. Relationship between attitudes toward mental illness and provision of pharmacy services. J Am Pharm Assoc (2003). 2010;50(6):704–713. doi:10.1331/JAPhA.2010.0904221071314
   PubMed Web of Science ®Google Scholar
• Al-Arifi MN. Community pharmacists attitudes towards mental illness and providing pharmaceutical care for mentally ill patients. Neurosciences (Riyadh). 2008;13(4):412–420.21063372
   PubMed Web of Science ®Google Scholar
• Aaltonen SE, Laine NP, Volmer D, et al. Barriers to medication counselling for people with mental health disorders: a six country study. Pharm Pract (Granada). 2010;8(2):122–131. doi:10.4321/s1886-3655201000020000725132880
   PubMedGoogle Scholar
• Cates ME, Burton AR, Woolley TW. Attitudes of pharmacists toward mental illness and providing pharmaceutical care to the mentally ill. Ann Pharmacother. 2005;39(9):1450–1455. doi:10.1345/aph.1G00915972325
   PubMed Web of Science ®Google Scholar
• Morera OF, Stokes SM. Coefficient α as a measure of test score reliability: review of 3 popular misconceptions. Am J Public Health. 2016;106(3):458–461. doi:10.2105/AJPH.2015.30299326885962
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Fialho A, Wijetunge A, Checinski K, Surgenor T. The stigmatisation of psychiatric illness: the attitudes of medical students and doctors in a London teaching hospital. Psychiatr Bull. 2002;26(5):178–181. doi:10.1192/pb.26.5.178
   Google Scholar
• Kondova A, Todorova A, Tsvetkova A, Arnaoudova M, Andreevska KGD, Grekova D. Screening and risk assessment for depression in community pharmacy – pilot study. J IMAB. 2018;24(1):1928–1931. doi:10.5272/jimab.2018241.1928
   Web of Science ®Google Scholar
• Rubio-Valera M, Chen TF, O’Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11(10):10967–10990. doi:10.3390/ijerph11101096725337943
   PubMed Web of Science ®Google Scholar